# Efavirenz

NDC: 65862-105
Generic name: Efavirenz
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20171215

FDA application: ANDA078064

## Active ingredients

- EFAVIRENZ: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-105"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-105
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c57ad7f-321a-46c8-851a-c895466eb8e1